FIELD: medicine.
SUBSTANCE: invention concerns a pharmaceutical industry, in particular, a composition possessing sedative and anxiolytic action. A pharmaceutical composition possessing sedative and anxiolytic action, containing motherwort extract, at least one pharmaceutically comprehensible compound of magnesium, vitamin B6 and auxiliary substances taken in certain parity.
EFFECT: reception of a composition which possesses increased sedative and anxiolytic action, and does not cause drowsiness.
3 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION AND KIT WITH ANXIOLYTIC ACTION | 2017 |
|
RU2703729C2 |
| MEDICATION BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD OF OBTAINING THEREOF (VERSIONS) | 2012 |
|
RU2563190C2 |
| COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR EXPRESS RELAXATION | 2016 |
|
RU2682888C2 |
| ANXIOLYTIC, SEDATIVE AND ANTI-STRESS MEDICINAL PRODUCT AND METHOD OF ITS OBTAINING | 2023 |
|
RU2814110C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| BIOLOGICALLY ACTIVE ADDITIVE WITH SEDATIVE-ANTIDEPRESSIVE EFFECT | 2016 |
|
RU2636471C1 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
| COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
| SEDATIVE MEDICINAL PRODUCT IN THE FORM OF TABLETS | 2021 |
|
RU2770037C1 |
